Navigation Links
BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device
Date:5/16/2011

FORT LEE, N.J., May 16, 2011 /PRNewswire/ -- BAETA Corp. (OTCBB: BAEA) announced today that the NYU School of Medicine will conduct a clinical trial to measure the efficacy of the Company's "MyHealthTrends for Pain" handheld device during intra-operative, pre- and post-surgical periods. This trial will compare the current standard of pain care monitoring to Baeta's device which facilitates accurate data collection.

Michael Haile, MD, director of Clinical Research at NYU School of Medicine will oversee the initiative as the Principal Investigator.  "We are interested in the practical application of a portable, handheld device for patients to quantify pain and the ability to translate this information into enhanced treatment regimens and outcomes relative to the current standard of pain care monitoring," said Dr. Haile.

The protocol has been reviewed and approved by NYU School of Medicine's Institutional Review Board (IRB).

"We look forward to the opportunity to determine if the standard of pain care monitoring can be advanced using this technology," said Dr. Alexander Gak, Chairman of Baeta Corp. "With limited tools to quantify pain, this is an important initiative for any individual suffering from acute or chronic pain," said Gak.  

Upon conclusion of the clinical trial Baeta intends to apply for a CPT reimbursement code. "This is an important step for Baeta Corp's commercialization of its advanced patient care products," stated Len Pushkantser, CEO of Baeta Corp. Physicians, hospitals, and other health care providers use CPT codes to report medical services to private and public health insurance systems for purposes of reimbursement. 

About Baeta Corp.

Baeta Corp. (OTC.BB: BAEA) is a technology-enabled he
'/>"/>

SOURCE BAETA Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BAETA Corp. Expands Market Awareness Programs
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... BEACH, Va. , May 4, 2015 /PRNewswire/ ... investment company focused on the lower middle market, ... Inc. ("BMS").  Founded in 1969 and based in ... provides a full range of radiation products for ... Fox Three partnered with Peninsula Capital Partners ("Peninsula"), ...
(Date:5/4/2015)... Thirty-six million Americans suffer from hearing loss, ... National Hearing Month – more than 28 million Americans ... the sounds of spring, like birds singing and the ... that you won,t be among those missing out on ... offers practical advice: Take action if you ...
(Date:5/4/2015)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) announced ... appointing  Donna M. Hughes, as Senior Vice President, Human ... Vice President, Chief Compliance Officer. Both Ms. Hughes and ... Executive Officer, Fred Wilkinson . "We ... Impax team," said Fred Wilkinson , President and ...
Breaking Medicine Technology:Fox Three Partners, LLC Acquires Burlington Medical Supplies, Inc. 2It's Better Hearing Month 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... 2010 WHAT:You are invited to demo a new tool ... Healthcare Co., Ltd. Currently applying for FDA clearance, this ... offering real-time detection of the thickness of the C-IMT ... the first comprehensive solution for screening and unlike ...
... MedInformatix, Inc. today announced that its full suite of ... to achieve certification under the U.S. Department of Health ... for Health IT,s Stage 1 meaningful use under provisions ... Austin, Texas-based Drummond Group Inc., one of ...
Cached Medicine Technology:Panasonic Unveils CardioHealth® Station - First Comprehensive Screening Solution to Detect Heart Disease in Asymptomatic Population 2MedInformatix' EHR Solutions Achieve ONC Meaningful Use Certification 2
(Date:5/4/2015)... City, NY (PRWEB) May 05, 2015 ... honors Shirley Weis as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... recognize Shirley with this important honor,” says NAPW President ...
(Date:5/4/2015)... The American Council of Engineering ... Chairman of Stanley Consultants , to the ... for a three-year term. , ACEC co-established ISI with ... Society of Civil Engineers (ASCE). A non-profit group, ... civil infrastructure called Envision. Launched in 2012, the Envision ...
(Date:5/4/2015)... Monkton, MD (PRWEB) May 04, 2015 ... affecting families for generations. While it can have ... in disabling and catastrophic events. Hereditary Hemorrhagic Telangiectasia ... of blood vessels that lack normal capillary connections between ... nose can cause frequent, severe nosebleeds, but may also ...
(Date:5/4/2015)... The University of California, Davis ... new initiative at UC Davis School of Medicine ... committed to advancing Latino health. , The program, ... Students to Be Physicians, (“Prep Médico” for short) ... mentorship and internship opportunities, a residential program, intensive ...
(Date:5/4/2015)... 2015 Each year, the Susan G. Komen ... and awareness for breast cancer. This year, Dr. Mark Deutsch ... as the entertainment sponsor for the 25th annual Susan G. ... at the Lenox Square Mall. , The Komen organization hopes ... raise $1.2 million. Perimeter Plastic Surgery has not only taken ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 3Health News:Thomopulos Appointed to Institute for Sustainable Infrastructure Board 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2
... Today results from a new sub-analysis of the EMPHASIS-HF ... five pre-defined high-risk patient sub-groups with chronic heart failure ... to standard therapy versus those treated with placebo and ... the first time during the European Society of Cardiology ...
... , SUNDAY, Aug. 28 (HealthDay News) -- An experimental ... warfarin in preventing strokes in people with the abnormal ... Over 2.6 million Americans are affected by ... Coumadin) to prevent dangerous clots that can cause a ...
... The 2011 Annual Meeting & OTO EXPO of the American ... the largest meeting of ear, nose, and throat doctors in ... CA. Featuring more than 386 scientific research sessions, 468 ... annual meeting is a unique opportunity for journalists from around ...
... patients prescribed a statin in a major trial that ended ... even though most participants in both groups have been taking ... stopped early because the statin was so effective at preventing ... that eight years on, the most significant difference between the ...
... -- As another school year begins, parents are reminded ... supplies can lead to back injury. "Parents should ... often carry much more than they should with extra ... Joshua Hyman, director of orthopedic surgery at New York-Presbyterian/Morgan ...
... , FRIDAY, Aug. 26 (HealthDay News) -- Rising cigarette ... sharp drop in smoking that occurred among black youth between ... early 1970s, smoking rates among black and white youth were ... However, the drop was much sharper among black youth. By ...
Cached Medicine News:Health News:The effect of eplerenone vs. placebo on cardiovascular mortality 2Health News:The effect of eplerenone vs. placebo on cardiovascular mortality 3Health News:New Blood Thinner May Outperform Warfarin for Irregular Heartbeat 2Health News:New Blood Thinner May Outperform Warfarin for Irregular Heartbeat 3Health News:2011 AAO-HNSF poster presentations 2Health News:2011 AAO-HNSF poster presentations 3Health News:2011 AAO-HNSF poster presentations 4Health News:2011 AAO-HNSF poster presentations 5Health News:2011 AAO-HNSF poster presentations 6Health News:2011 AAO-HNSF poster presentations 7Health News:2011 AAO-HNSF poster presentations 8Health News:2011 AAO-HNSF poster presentations 9Health News:2011 AAO-HNSF poster presentations 10Health News:2011 AAO-HNSF poster presentations 11Health News:2011 AAO-HNSF poster presentations 12Health News:2011 AAO-HNSF poster presentations 13Health News:2011 AAO-HNSF poster presentations 14Health News:2011 AAO-HNSF poster presentations 15Health News:2011 AAO-HNSF poster presentations 16Health News:2011 AAO-HNSF poster presentations 17Health News:2011 AAO-HNSF poster presentations 18Health News:2011 AAO-HNSF poster presentations 19Health News:2011 AAO-HNSF poster presentations 20Health News:2011 AAO-HNSF poster presentations 21Health News:Statins reduce deaths from infection and respiratory illness, 8 years on from trial 2Health News:Expense May Be Causing Fewer Young Blacks to Smoke 2
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Liquid buffer and dry powder r...
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... The stainer TST 44 is an "assembly-line ... in histology and cytology laboratories. It automatically ... time. Its again increased large number of ... working principle provides a high throughput. Up ...
... in automatic slide stainers. It offers a ... staining, ending messy procedures. The instrument of ... and other body fluids. With the optional ... superb cytocentrifuge with eight-slide capacity and full ...
Medicine Products: